The landscape of orthopaedic surgery is undergoing a profound transformation. Moving beyond the traditional focus on hardware—the titanium alloys, the 3D-printed lattices, and the surgical instrumentation—the industry is increasingly shifting its gaze toward the "human element" of care. Leading this charge is restor3d, a pioneer in personalized orthopaedic solutions, which has officially launched MyFit by restor3d Digital Suite. This comprehensive platform represents a strategic evolution, designed to bridge the communication gap between surgeons, care teams, and the patients who rely on them.
By integrating automated messaging, interactive 3D visualization, and long-term outcome tracking, the suite seeks to transform the often-opaque world of joint replacement into a transparent, collaborative journey.
The Core Innovation: Redefining Patient-Centric Care
At its heart, MyFit by restor3d is a digital ecosystem designed to extend the company’s signature philosophy—personalization—beyond the operating room. For years, restor3d has distinguished itself through the development of patient-specific implants. However, the company recognized that a custom-fit implant is only as effective as the patient’s understanding and engagement with their recovery process.
The platform functions as a digital concierge for the orthopaedic journey. It facilitates real-time communication between patients and their clinical teams, ensuring that anxiety-inducing "black boxes" in the care process—such as the wait time between initial consultation and surgical scheduling—are filled with meaningful updates. By automating the flow of information, the suite empowers patients to feel like active participants in their healing rather than passive recipients of a procedure.
A Chronology of Integration: From Concept to Launch
The launch of the MyFit suite is not an isolated event but the culmination of a broader roadmap to digitize the entire orthopaedic lifecycle.
- Early Development Phase: Recognizing that high-end 3D-printed implants were becoming a standard of care, restor3d began identifying bottlenecks in patient communication. The goal was to build a system that wouldn’t burden surgeons with administrative overhead.
- April 2025: The Regulatory Milestone: The foundation for this digital expansion was reinforced by the US Food and Drug Administration (FDA), which granted 510(k) clearance for the company’s cementless iTotal Identity CR 3DP Porous Total Knee Replacement System. This clearance proved that the company’s hardware was robust, allowing them to pivot their development resources toward the software and engagement layer that would eventually become MyFit.
- The Pilot and Refinement: Throughout 2025 and early 2026, the company tested various iterations of the platform across diverse orthopaedic specialties, ranging from hip and knee replacements to complex foot and ankle reconstructions.
- September 2026: Official Launch: The suite was formally introduced, marking the transition of restor3d from a purely medical device manufacturer to a comprehensive "orthopaedic solutions provider."
Supporting Data: Tailored Experiences for Diverse Procedures
The strength of the MyFit platform lies in its segmentation. Recognizing that a knee replacement patient has different psychological and recovery needs compared to a shoulder or ankle patient, restor3d has bifurcated the suite into two specialized branches:
MyFit Connect for Hip and Knee Patients
For patients undergoing the most common joint replacement procedures, the platform utilizes MyFit Connect. This tool relies on automated SMS notifications that guide the patient through the lifecycle of their custom implant. From the initial enrolment and the design phase to the precision manufacturing of their specific device and finally the preparation for surgery, the patient is kept informed. This continuous "nudge" strategy is proven to reduce preoperative anxiety and improve patient compliance with surgical protocols.
The Interactive Portal for Shoulder, Foot, and Ankle Patients
For more specialized procedures, where anatomical complexity is higher, patients receive access to an interactive portal. This portal removes the friction of digital security by utilizing a password-free, identity-based access system. Once inside, patients can track the status of their implant and, crucially, interact with a 3D model of their own device. Being able to visualize the exact implant designed for one’s own anatomy has been shown to build significant trust between the patient and the surgical team.
The Patient-Specific Registry
Beyond individual care, the suite serves as a data powerhouse. The restor3d Patient-Specific Registry is currently targeting 2,250 participants. By collecting patient-reported outcomes (PROMs) from baseline through the five-year post-operative mark, the registry creates a feedback loop. This data is vital for continuous improvement in implant design and helps clinical practices meet regulatory and quality benchmarks with minimal effort.
Official Perspectives: The Vision of Kurt Jacobus
The philosophy driving this digital shift is rooted in the belief that technology should humanize medicine, not complicate it. restor3d CEO Kurt Jacobus emphasizes that the modern patient is significantly more informed and engaged than those of previous decades.
"Personalisation has always been at the centre of what we do at restor3d," Jacobus stated during the launch. "MyFit allows us to bring that same philosophy directly to the patient experience. Patients undergoing joint replacement are increasingly engaged in their care and want to better understand the technology and treatment designed specifically for them."
Jacobus also highlighted the dual benefit of the platform: while it provides the patient with a unique connection to their personalized hardware, it simultaneously provides the company with a longitudinal view of clinical outcomes. By learning from how patients fare in the years following surgery, restor3d can refine its 3D-printing parameters to ensure better long-term durability and patient satisfaction.
Implications: The Future of Orthopaedic Practice
The introduction of the MyFit suite has significant implications for the future of the medical device industry.
1. The Death of Administrative Burden
One of the primary barriers to the adoption of patient-engagement software in hospitals has been the fear of "alert fatigue" or increased administrative load for clinicians. restor3d has addressed this by automating the most frequent touchpoints. By keeping the patient informed via the app, the suite effectively reduces the number of phone calls and emails reaching the surgeon’s office, allowing clinical teams to focus on medical care rather than scheduling and status inquiries.
2. Standardizing the "Personalised" Experience
Historically, "custom implants" were a boutique service—expensive, slow, and reserved for only the most complex cases. By scaling the digital infrastructure, restor3d is lowering the barrier to entry for personalized orthopaedics. The platform makes the process feel seamless, which in turn encourages more surgeons to offer patient-specific solutions as a standard of care rather than a last resort.
3. Data-Driven Orthopaedics
The integration of the Patient-Specific Registry into the engagement platform is a masterstroke in clinical research. Typically, gathering five-year post-operative data is notoriously difficult, plagued by high drop-out rates. By making the portal a valuable resource for the patient, restor3d increases the likelihood that they will continue to log in and provide data, thereby creating a robust, high-quality dataset that will inevitably influence the next generation of implant design.
4. Competitive Positioning
With the FDA clearance of their cementless knee systems and the launch of this digital suite, restor3d is positioning itself to disrupt larger, more traditional orthopaedic conglomerates. While competitors are often siloed—selling hardware in one department and software in another—restor3d is building an integrated "full-stack" model. This convergence of manufacturing (3D printing) and software (MyFit) creates a formidable moat that will be difficult for legacy manufacturers to replicate without significant internal restructuring.
Conclusion: A New Standard for Patient Recovery
The launch of the MyFit by restor3d Digital Suite marks a turning point in how medical technology companies interact with the end-user. By acknowledging that a successful orthopaedic outcome is defined not just by the mechanical stability of an implant but by the patient’s confidence and comfort throughout the process, restor3d is setting a new industry standard.
As the platform scales to cover its projected 2,250 registry participants, the insights gained will likely lead to even more nuanced, patient-specific solutions. In an era where digital health is no longer a luxury but a necessity, restor3d has successfully demonstrated that when you design for the patient’s peace of mind, you improve the health of the entire system. For surgeons, the suite offers a promise of efficiency; for patients, it offers the promise of clarity. In the complex world of orthopaedics, that is a transformative combination.
About the Author
